WHAT WE DO

Image Analysis Group (IAG)  has been a valued partner to biotech and pharmaceutical companies for nearly 20 years. We are optimizing clinical trial design and delivery through our award-winning platform DYNAMIKA and AI-powered endpoints, accelerating the assessment of efficacy and safety for novel drug candidates to ultimately deliver the promise of health and longevity to people worldwide.

As a leading Imaging Clinical Research Organization (iCRO), we combine cutting-edge technology with a robust operational infrastructure, ensuring seamless execution of clinical trials across the globe. Our extensive reach and expertise enable us to support pharmaceutical and biotech companies in achieving their clinical development goals efficiently.

Operational Excellence 

Global Presence: Our operational teams and project managers are strategically located in the UK, EU, USA, India, and partnership in China and Australia providing comprehensive support for phase 1-3 trials and real-world studies.

Experienced Project Management: Our seasoned project managers have a proven track record of successfully managing complex clinical trials, ensuring timely delivery and adherence to regulatory standards.

Global Site Netwrok: We maintain a well-connected network of sites and radiology readers, facilitating rapid site set-up and efficient data collection.

Innovative Solutions

DYNAMIKA: Our proprietary Digital Data Management infrastructure maximizes efficiencies in handling imaging data, offering streamlined site set-up, monitoring, and advanced image review capabilities.

AI-Powered Endpoints: We leverage advanced AI algorithms to analyze vast amounts of data, enhancing safety assessments and improving efficacy evaluations.

Therapeutic Expertise

Our team has extensive experience in a wide range of therapeutic areas, including musculoskeletal disorders, oncology, immunology, obesity, rheumatology, neuroscience, CNS disorders, and rare diseases. This expertise, combined with our Medical and Scientific advisory teams, supports optimal trial design and protocol development.

Since 2007, we’ve successfully delivered over 700 clinical trials, continuously pushing the boundaries of what’s possible in clinical research. Our commitment to operational excellence, innovative technology, and patient-centric approach positions us at the forefront of the industry, driving the development of better medicines, faster.

At IMAGE ANALYSIS GROUP, we’re not just transforming clinical trials – we’re accelerating the path to a healthier, longer-living world through effective partnerships and cutting-edge solutions.

Read more about our partnerships

CONTACT | REQUEST FOR INFORMATION

TRIAL DESIGN & STRATEGY

By leveraging statistical methods, imaging data analytics, and deep medical knowledge, we identify the most efficient and effective trial strategies.

We meticulously evaluate factors such as patient populations, study endpoints, and experimental designs to ensure that trials are well-powered, minimize risks, and maximize the likelihood of achieving meaningful results. Additionally, IAG’s team collaborates closely with regulatory bodies and ethical review boards to navigate complex guidelines and ensure compliance with industry standards.

This comprehensive approach enables IAG to deliver high-quality clinical trials that contribute to the development of innovative and safe medical treatments.

TRIAL DELIVERY

IAG team are focused on streamlining clinical trials through process optimization, data management and result transparency.

By simplifying procedures, employing state-of-the-art data management system DYNAMIKA and quality control measures to ensure data accuracy, integrity, and accessibility, we facilitate real-time monitoring, data analysis, and reporting, enabling informed decision-making throughout the trial.

By maintaining open communication with all stakeholders, including sponsors, investigators, and regulatory bodies, IAG fosters trust and collaboration. This transparency extends to data sharing, reporting, and compliance, ensuring that all parties have access to relevant information and are kept informed of project progress.

Cost-efficiency is another key focus for IAG. The project team employs strategies to optimize resource allocation, minimize operational costs, and maximize the return on investment. This includes careful budgeting, efficient trial design, and the use of cost-effective technologies. By identifying and implementing cost-saving measures, IAG helps clients achieve their clinical trial objectives while minimizing expenses.

OUR CLIENTS

We foster strong collaborative relationships with our clients by providing personalized support throughout the entire clinical trial process. The team works closely with Sponsors, sites, readers, and regulatory bodies to understand their unique needs and objectives. This collaborative approach ensures that the trial design and execution align with the client’s goals, while also adhering to regulatory requirements.

Our team dedication to client satisfaction is evident in the ample positive feedback. Clients often praise IAG for its:

  • Expertise and knowledge: Clients appreciate IAG’s deep understanding of clinical trial methodologies, regulatory guidelines, and industry best practices.
  • Efficiency and timeliness: IAG’s streamlined processes and commitment to meeting deadlines are frequently commended by clients.
  • Communication and transparency: Clients value IAG’s open and honest communication, which fosters trust and collaboration.
  • Flexibility and adaptability: IAG’s ability to adapt to changing circumstances and address challenges promptly is often highlighted.
  • Quality and reliability: Clients consistently praise the high quality of IAG’s work and their reliability in delivering successful trials.

By building strong partnerships and consistently exceeding client expectations, IAG has established a reputation as a trusted and reliable partner in the clinical research industry.

Global Client Services:  Clinical Trials
At IAG, we strategically use imaging based endpoints, network of sites and radiology readers to accelerate your trial outcomes and lower investment risks into R&D. Whether you are entering a phase I-III and need early robust efficacy data or planning A.I. innovation project, our  Medical and Scientific experts, operations, and technology teams will work with you to develop the right solution and help with the delivery.
We strategically use imaging, such as MRI, CT, and PET to accelerate drug development and lower investment risks.

Imaging.Experts@ia-grp.com 

DYNAMIKA, Image Management Platform
IAG’s proprietary platform DYNAMIKA supports seamless data collection, real-time image Quality Control, analytics, and data ingestion. DYNAMIKA brings AI / ML into trial process to allow for a fully transparent data management, trial execution control and central review.

 

Client Testimonials

Since 2007, IAG supports clinical trials and real-world evidence studies for biotech and pharma clients. Read more on how we helped! 

Quality Management

Rigorous quality standards, our products and processes adhere to ISO13485 and other industry standard requirements. Our Quality Management System is certified by the British Standards Institute (BSI).